1.
Mantovani LG, Cortesi PA, Cardillo A, et al. Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 2022;23(1). https://doi.org/10.7175/fe.v23i1.1510